Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, I would agree with you that they are very interesting breadcrumbs.
I also realize that my research was rather cursory, not much more than searching a handful of databases and combing through some records. I could have done more, but what turned up was damning enough in my opinion.
On the other hand, the totality of the circumstantial evidence is what’s so alarming.
Another member on the board did some deeper diving and even found some records showing Carl Dilley being the owner of Transhare in the not-too-distant past.
At the end of the day, however, I’m not the judge or jury, so I can’t make a determination of guilt.
But, I tend to think that if it looks like a chicken, walks like a chicken, and squawks like a chicken - it’s probably a chicken.
Yup, the SEC forms you posted tell the story.
Notice that out of all of the transactions last year, insiders (Marco) only made ONE purchase of CANB.
Every single other transaction was them selling - MILLIONS.
The form shows you that (A) means acquired, and that (D) stands for DUMP!
They dumped their shares from $.01 - .04, with and average probably around the $.03’s.
On many days, Marco and Rolv made up as much as 30% of the trading volume!
On days where Marco and Rolv went into super-dump mode, the price dropped more than 20%!
If they’re dumping so heavily, and with no concern about their impact on share price, do you think they really care about the long-term viability of this “company”?
Ask yourself, is it usually a good sign that insiders are virtually never buying and almost exclusively dumping their shares?
Yes, Wednesday. The financials are due Wednesday, don’t count on them coming out that day, however.
CANB is usually late, so you’ll have to hold your breath until next week.
But when they do come out, only a fool WOULDN’T sell!
CANB’s numbers will look incredible, as if it’s too good to be true!
You know it means when something looks too good to be true - it usually ISN’T TRUE!
Do yourself a favor, ride the momentum to the mid-$.07’s, maybe $.08’s, then bail out of this thing like it’s a sinking ship.
The fools will be the one’s who hold on and ride this back down to $.03, where all the insiders are happily dumping their shares.
Refusing to accept the overt fraud is smart investing?
There will always be those who refuse to accept the truth, even when it stares them in the face.
Someone said that they went to Canbiola’s facility. They saw 4 whole people working, which included the owner and his son.
Does that seem like a million dollar company to you?
Don’t be so gullible.
At best, this touches $.10 just long enough to sell off. If you don’t sell at $.10, you must not like making money.
If you didn’t sell around $.06, you’re overestimating Canbiola.
$.05 just fell, $.04’s are next.
Insiders dumped millions at $.03, so they’re next.
If you’re long, you’re losing money.
At best, this is a quick flip play. There is no long-term future here.
Island Stock Transfer made as many as 20 companies seem like viable businesses.
Fully reporting, legitimate seeming companies.
Island Stock Transfer is Transhare Corporation.
Is Canbiola the one “real” company represented by these scammers, or is it just more of the same?
Yes, Q1 will be “great,” but will the numbers be real?
Oliver Wendell Holmes said it best, that we should “wash [everything] with cynical acid and expel everything except the object of our study.”
I implore you, be cynical. Ask the hard questions. Seek the most plausible truth.
Excuse your own biases and motivations.
Do you really want Canbiola to succeed? So do I!
However, yours and my desire for Canbiola to succeed has no impact on the daily on-goings of the company, nor the outcome of their business.
On a totally objective basis, what can we extrapolate from the evidence? Does it look good? Does it look questionable? Or does it look like an outright sham?
If you can approach the subject from a genuinely objective place, you’ll agree with me - this is an outright sham.
Like I’ve mentioned in my posts recently, I do think Canbiola has potential from here.
However, that potential is much more restricted than I originally projected.
Will Canbiola reach $.10 again? Maybe.
Will they reach $1.00? Not a chance.
They’ll never really exceed the way we all originally hoped, because it’s now very clear that they are just as much a share-selling company and they are a CBD company.
Every time Canbiola inches towards new highs, it will be massively sold off by insiders.
This was suggested by others months ago, and I didn’t want to believe it, but now I can’t rationally disagree.
I think the best course of action from here is to proceed with caution and restrain your optimism.
At best, maybe you can flip some shares, but I wouldn’t want to be holding the keys to a house of cards for any extended periods of time.
When you put all the pieces together, you can finally see what the puzzle is.
1) fraudulent transfer agency (share selling scammers) rehired,
2) authorized share count increased to 1.5 billion, even when the company is reporting decent revenue,
3) millions of shares being sold by insiders at $.02 - .04/share.
I wouldn’t give the insiders the benefit of the doubt here.
Insiders probably don’t care to see CANB go much higher from here because they’re selling millions of shares at almost double the price they were getting last year, and retail investors are buying from them because they think they’re getting discounted prices before CANB goes on the epic run they’ve been promised.
I once thought CANB would be the CBD superstar that everyone else does, but being a rational investor, I can’t ignore the writing on the wall.
Companies make adjustments and move on?
Let me break it down:
1) Canbiola hired fraudulent transfer agency.
2) Fraudulent transfer agency got busted.
*Canbiola’s “adjustment”*
3) Canbiola hired the same busted frauds to continue being their transfer agent
Is that the “adjustment” you’re talking about?
If so, not the kind of adjustment I’d like to see a company make.
You said some action was taken. I’m wondering if you are under the impression that Canbiola has taken some action regarding their shady transfer agency.
The only action they’ve taken is that they hired the same agency they fired with a new name - both run and owned by Carl Dilley at some point.
I’m afraid you may not fully understand the situation, but are deciding to ignore it instead.
What action was taken?
This happened 3 weeks ago...
Is it really old news?
Beyond that, prosecutors are very familiar with the burden of proof - it’s their job.
Knowing what their burden of proof is, do you think they’d bring a case if they didn’t have sufficient evidence? Probably not.
I don’t think anyone doubts the numbers will be “great.”
I think the recent correlation between Canbiola’s new transfer agency and their old transfer agency raises doubts about their legitimacy.
Can the “great” numbers really be trusted?
I ask this in earnest. I genuinely want to know what other people think about the overt potential for fraud here.
I know some may be concerned, others may not be. But why? Why are some not concerned, why are others concerned?
There is more to it than “trusting CANB,” or ignoring the obvious signs. What is the thought processes that supports the confidence behind Canbiola, aside from the fact that they report pleasant revenue?
Hey, don’t get me wrong, I realize the whole “innocent until proven guilty” thing.
Like I’ve mentioned in the past, I’m going into my final year of law school - I get the judicial process.
However, the judicial process isn’t so black and white. Beating a charge doesn’t prove innocence, the same way be able to meet a burden of proof doesn’t guarantee guilt.
What I can say is this: charges are usually brought when there is a strong case.
Having a case because someone did something wrong and being able to prove it are two different things.
Actually proving that case will be a matter of fact and/or law to be decided by a fact finder, likely a judge or a jury.
Nonetheless, you’re right about the main take-away being that investors should be cautious.
After all, nobody really cares if they’re right or wrong, we’re all just here to make money.
Like Sleek mentioned earlier, $.05 didn’t hold.
From a technical perspective, today’s sell off was likely attributed to the failed support at $.05, and we are probably headed back to the mid-$.04’s.
If that fails, we could easily see $.03’s again.
This is all based on a technical analysis of the chart, and has nothing to do with the swirling rumors that buzz iHub.
In fact, I tend to think that iHub has virtually no impact on the way a company trades, and is really just a place for traders to chat.
For the most part, a company will trade the way it naturally trades. Most of it can be explained by technical analysis and market climate.
On that alone, I think we’re going lower.
I appreciate confidence, believe me.
But, as a rational investor, are you even considering the fact that Canbiola may still be doing shady stuff that exposes investors to harm?
CANB under $.10 is a joke?
In almost 3 whole years, Canbiola has traded over $.10 for a microscopic 4 DAYS. Really, we’re talking a handful of hours where it touched $.10 and then tanked back to $.03.
How is CANB under $.10 a joke, it actually seems like the norm.
This is the true essence of what this forum is about.
An issue is raised, albeit uncomfortable or unpopular, and it encourages others to dig into it.
Ultimately, everyone on the board is more enlightened because of it.
I’m glad to see you found another layer of information that wasn’t able to.
I should elaborate though.
I do have a guitar, I just can’t play it.
Yeah, I don’t doubt that there is some degree of business being conducted.
I just think that the expectation that Canbiola could be the next CBD Unlimited, or even CV Sciences, is out the window.
What I do think is a more realistic future for Canbiola is for them to run their “business” to enough degree that they can dilute the heck out of investors.
That’s disappointing because I thought there was way more potential here.
Canbiola fired Island Stock Transfer last month and Carl Dilley resigned.
Carl Dilley owned Island Stock Transfer, and he was charged with fraud for making dozens of shell companies seem legit and selling them to investors.
After firing Island Stock Transfer, Canbiola rehires them with a new name - Transhare Corporation.
Canbiola seems legit to most, including me to some extent.
The problem that I’m seeing is, how do we know Canbiola REALLY IS LEGIT?
After all, they did just increase their authorized share count to 1.5 billion.
Initially, I thought the increase was nothing, probably just done to help finance their seemingly legitimate business operation.
Now, I’m not so sure. After all, selling shares of seemingly legit companies is what IST (now operating as Transhare) is known for.
I realize that Canbiola submitted audited financials. If you read the charges brought against Carl Dilley, that was his M.O. - make these companies look real, defraud the SEC, DTC, and FINRA, and sell some shares.
Therefore, relying on the reported financials to prove that Canbiola is a legitimate business is falling for the same exact scam that Carl Dilley and Island Stock Transfer ran for years.
There has to be more going on here...
All I’ve done is be honest with this board about the research I’ve done on Canbiola. It’s not much, it was a few searches on a few state websites, but it turned up plenty enough.
Nonetheless, redirecting the argument toward me, suggesting that I have something to gain, doesn’t address the real issue - why would Canbiola fire Island Stock Transfer publicly, then basically rehire them privately under a new name?
This isn’t just speculation - there is a VERIFIABLE paper trail!
Do the research, report objectively, form an opinion.
Don’t form an opinion, do some research, then report your opinion.
I’d just like to point out that I’m not dredging up any “old news.” Just last month, Canbiola announced they were dropping Island Stock Transfer due to the fraudulent activity the company was being investigated for. Moreover, the owner of Island Stock Transfer and director for Canbiola, Carl Dilley, resigned immediately after. Thus, they hired Transhare Corporation. After searching through public business records, it has become apparent that Island Stock Transfer has been reincarnated as Transhare Corporation. Very relevant, and very current.
I like the argument for revenue just as much as anyone else, believe me. I want Canbiola to succeed also.
However, the fact is that the transfer agency they were using was known for selling securities from shell/scam companies - companies they made full reports on just to make them appear viable to potential investors.
The new transfer agency is actually the old transfer agency.
That is extremely problematic for investors. Is Canbiola a viable company, or are they another scam made to appear viable for investors?
It’s impossible to say at this point, but the correlation is too likely for me to ignore it.
My principle concern is that Canbiola gave investors the impression they were no longer affiliated with Carl Dilley, nor Island Stock Transfer. The truth is, they still are.
To me, that’s the most concerning piece of information because of the charges brought against Carl Dilley and the allegations against his business conduct.
Here is an excerpt from allegations brought against him:
“3. This action involves Defendants’ roles in one or two separate fraudulent schemes from approximately December 2009 through August 2014 to manufacture at least 19 public companies for sale fundamentally premised on a deceptive public float of purportedly “free-trading” securities: 14 by Alvin Mirman and Sheldon Rose (the “Mirman/Rose Companies,” identified in paragraph 30 below) and five by Michael Daniels, Andy Fan, and Diane Harrison (the “Daniels Companies,” identified in paragraph 102 below).
4. The fraudulent schemes depended on misrepresentations and omissions to, among others, the Commission, the Financial Industry Regulatory Authority (“FINRA”), and the Depository Trust Company (“DTC”) that the Mirman/Rose and Daniels Companies were legitimate small businesses with independent management and shareholders. In reality, both the management and shareholders were nothing more than nominees for control persons who always intended merely to sell all the securities of the companies privately in bulk for their own benefit. The essential value of these securities (each bulk sale realized proceeds of hundreds of thousands of dollars) was their false designation as “free-trading” with the ability to be sold immediately on the public market. If the truth had been known to the public, the securities would have been restricted from such sales and would have had little value.
5. Dilley and Eldred knew or were reckless in not knowing from the onset that the Mirman/Rose Companies and Daniels Companies, respectively, were pursuing their stated plans under false pretenses and instead being packaged for sale as public vehicles, and that the shareholders were mere nominees for the control persons. Nonetheless, Defendants took critical steps to advance the frauds.
6. Dilley schemed with Mirman and Rose, and Eldred schemed with Daniels, Fan and Harrison, to defraud the public that the Mirman/Rose Companies and Daniels Companies were operating businesses with independent management and shareholders, rather than undisclosed “blank check” companies (sometimes referred to as “shells” or “vehicles”) for sale. In furtherance of the Mirman/Rose scheme, Dilley signed false Form 211 applications submitted to FINRA, contributed to false DTC applications, found potential shell buyers, signed an escrow agreement and false attestation letters for shell buyers, and effectuated the bulk transfer of the entire deceptive public float of Mirman/Rose Companies to shell buyers. Eldred similarly schemed with Daniels, Fan and Harrison by filing false Forms 211 with FINRA, signing false securities deposit forms and executing trades in Spartan Securities’ proprietary account, all in support of the manufacture of undisclosed public vehicles – one of which Eldred expressly proposed to acquire himself while its Form 211 was pending.
7. A necessary step in both fraudulent schemes was for the issuer’s stock to be eligible for public quotation, which requires a broker-dealer to file a Form 211 application with FINRA to demonstrate compliance with Rule 15c2-11 under the Securities Exchange Act of 1934 (“Exchange Act”). FINRA typically raises specific concerns or seeks further information from the broker-dealer in one or more deficiency letters before clearing the application. Meanwhile, transfer agents perform a number of roles for issuers pertaining to their securities and shareholders, including recording changes of ownership, maintaining the issuer’s security holder records, canceling and issuing certificates, and resolving problems arising from lost, destroyed or stolen certificates.
8. Spartan Securities and Island Stock Transfer acted in tandem to provide these various services which were critical to the Mirman/Rose and Daniels/Fan/Harrison shell factories. For example, Spartan Securities filed the Form 211 application with FINRA in order for the securities of these 19 issuers to be publicly quoted. Spartan Securities, Dilley, and Eldred made materially false statements and omissions to FINRA regarding the purpose, management and shareholders of the Mirman/Rose Companies and Daniels Companies. Spartan Securities and its principals also had information that undermined any reasonable basis that the information required by Rule 15c2-11 was materially accurate and from a reliable source. Spartan Securities then initiated unpriced quotations for all the Mirman/Rose Companies and Daniels Companies (except PurpleReal) upon FINRA’s clearance of the Form 211.”
The big problem is that it appears Canbiola is still using Island Stock Transfer under the guise of a new company, Transhare Corporation.
If that’s true, Carl Dilley is likely still involved to some extent here, and he has a documented history of using investor money to line his own pockets. The man intentionally defrauded investors, lied to the Financial Industry Regulatory Authority (FINRA), lies to the Depository Trust Company (DTC), and lied to he U.S Securities and Exchange Commission (SEC).
Although I loved Canbiola, and I want to see them succeed, I’m not willing to let my money end up in his pockets. I’ll be sitting this one out.
Island Stock Transfer is owned and ran by known fraudsters - literally, the owner was charged with fraud by the SEC.
Island Stock Transfer = Transhare Corporation.
If that’s true, Transhare is necessarily run by the same fraudsters, and likely in the same fraudulent way.
Some questions that I asked myself:
Why is Kim Whiteside the only identifiable employee of Transhare, and also an employee of Island Stock Transfer?
Why doesn’t her only telephone number work?
Why can’t you get ahold of anyone else at the company during normal business hours?
I hate to be the bearer of bad news, and I also had high hopes for Canbiola, but shady practice is shady practice.
If you’re willing to throw your money at a company like this and ignore the facts, you might as well be throwing your money at the Powerball, because irrational investing is really just gambling.
Thanks, yours too! And I’ll check that other company out, thanks for the heads up.
I tend to agree with that perspective, actually.
Like I said, I don’t like what I’ve found but I still recognize Canbiola’s potential in the CBD market, primarily because they DO have a product, and it appears that they DO have revenue coming in.
There’s no inconsistency, I’ve been more transparent than most here.
I’ve traded the company since last year. My first position was about 40,000 shares, my last position was about 220k shares.
I was planning on buying back in at around $.05 - .055, until I started looking more into their transfer agency issue recently.
Once I connected all the dots, my strategy changed - which I’d expect any rational investor/trader to do.
At this point, I’m not sure I would take such a huge position (300k +) because of the risk I think their business practices impose on investors.
Like I said, take the information for what it’s worth. I laid out clear, public information that anyone else could verify. What you do with it, including criticize me, is up to you.
I preface this post with a few disclaimers:
1) although I currently have no position with Canbiola, I have been long in the past.
2) even though I think this discovery suggests shady business practices, I am still hopeful for Canbiola’s future in the CBD market.
3) I have tried to be very objective in my analyses of Canbiola, and not disclosing the following information would mean that I am no longer acting objectively. After all, you have to take the good with the bad.
4) finally, the broker I use does not allow me to short Canbiola, so I have nothing to gain by posting this information.
With that being said, I finally have to disclose some information that I came across when I first read Canbiola’s 10-K back in April.
For those of you who remember, Canbiola recently released Island Stock Transfer (IST) as their transfer agent due to the fraud charges brought against Carl Dilley - who was the owner of IST and also a director for Canbiola.
More or less, he was charged with selling securities for dozens of sham companies. Basically he was selling shares for fake companies and keeping investor money. For obvious reasons, he resigned from Canbiola soon thereafter.
Well, after that, Canbiola hired a new transfer agent: Transhare Corporation.
At first, I thought “wow, great to see them dump the scammer and hire someone else,” I even posted about it on this board. Until, I started digging.
What stood out to me at first was the address. Both companies, IST and Transhare are located at the same address: 15500 Roosevelt Blvd, Clearwater, FL 33760.
The only difference is that IST’s office is in Suite 301 and Transhare’s office is in Suite 302 - the very next office door over.
I didn’t want to make any assumptions, because they could just be located in some financial district after all. So I looked the building up on google maps and got a street view of the office. It’s just a big, typical office building. Nothing fancy, just a building with a bunch of offices inside.
At this point, questionable - sure, but not throwing red flags quite yet.
Then I started looking into both companies: who runs these companies, anyway?
I googled Transhare Corporation and got a company out of Colorado, so I went to the Colorado Secretary of State’s website and searched for them there.
Sure enough, Transhare Corporation is a Colorado corporation with their principle place of business established at the Clearwater, Florida address given above.
Knowing that the Transhare Corporation that Canbiola reported hiring and the Colorado company that came up on Google we’re the same, I called the phone number that came up on Google. I called it at midnight, I called it at 7am, I called it at 10am, and I called it at 2:30pm. Every single time, it went straight to a voicemail. No ring, just voicemail. I did this over a three-day period, calling around the same times. Nobody ever answered the phones. What I did hear though, was a voicemail box for a ‘Kim Whiteside.’
So, I googled “Kim Whiteside Transhare Corporation.” The very first thing that came up was a LinkedIn profile for a Kim Whiteside - Operations Associate at ISLAND STOCK TRANSFER. Everything else that came up was for a Kim Whiteside and her association with Island Stock Transfer.
Now, I don’t know how many Kim Whitesides there are in the world, but I find it odd that there could be a Kim Whiteside working as a supervisor at the company Canbiola just fired, and also a Kim Whiteside working at the new company they just hired - which happens to be based out of the same town, in the same state, in the same building, in the very next office over.
Instead, I think Canbiola tried to distance itself from a known fraudster and a company with a terrible reputation publicly, but wanted to maintain their business relationship with the same fraudsters and same shady company privately.
What’s worse, is that they fired known fraudsters and a company charged with operating and selling securities for sham companies, but then they hired what can only be the same fraudsters who are operating what seems like another sham company!
If that’s the case, which it looks like it is, that’s a hard stop for me. The truth is, OTC companies have bad reputations by virtue of being listed on OTC exchanges. When they engage in highly questionable business practices, it gives credence to those negative suspicions. Even when otherwise straight-laced companies get suspected of shady things, it almost always ends badly for investors.
For example, when CV Sciences was accused of withholding material information from investors last year, although they were probably in the clear, their stock tanked from $9 to $3 in a few days. The following weeks brought an onslaught of litigation and investigations.
I don’t want to be on the losing side of Canbiola if something like this - or worse - gets out.
Will Canbiola ever hit $1.00, or even $.40, who knows? With their now “secret” association with known fraudsters, I think the possibilities are much slimmer.
For everyone who takes the time to read this board, take this information for what it’s worth. Follow my trail, perform the searches yourself. Re-read the 10-K. The information is available, and maybe it’ll help you in your decision-making process before you buy/sell Canbiola in the future.
Although this is really not the best news, I hope it’s beneficial to some!
Good luck to everyone!
Looking at the daily chart, we had a similar setup near the end of January. Once the 14-day SMA crossed above the 50-day SMA, we ran straight to $1.50.
As of today, we are holding the same support level that we held in January, and the 14-day SMA is about to cross the 50-day SMA again.
I expect we’ll cross tomorrow or Monday, depending on how we open in the morning. Nonetheless, very bullish setup developing here.
Beyond that, there is still a very high percentage of the float being shorted, so I expect another squeeze coming - again, either tomorrow morning or on Monday. This should be the big push to $1.50 we’ve all been waiting for.
Good luck to everyone!
It’s undeniable, there has been a considerable uptick in big-box store activity in the CBD/hemp market this year.
I live in Texas, and the last time I went to Walmart I found hemp-based shampoo and body wash for sale. If anyone can explain to me how to upload images, I’ll post the picture of the product as it sat on the shelf.
What stands out even more to me though, is the amount of CBD/hemp retailers popping up that aren’t big-box. There are entire store fronts opening up that sell nothing but CBD/hemp-based products. In Texas, you’d think this is impossible - “weed” stores?! But nope, they’re in the mall, they’re in strip centers, they’re everywhere.
To see the big-box retailers, along with small business operators, accepting CBD/hemp-based products the way the are only means one thing: this is the beginning of a cultural revolution.
As an investor, that tells me one thing: throw every penny you have at CBD/hemp and watch the money roll in!
I would have liked to see us hold $1.00 today, but that’s okay. All isn’t lost, yet.
Looking at the hourly chart, we successfully checked the 50-day SMA today. The last time we checked the 50-day SMA, we ran from $.50 to $1.00. I think we needed a good bounce off of the 50-day SMA before we close above $1.00.
The daily chart is still looking pretty good. There is plenty of support at $.88 - .89. Pull backs are typical, and even welcomed, especially after the huge gains we’ve seen these past few days.
Nonetheless, I tend to agree with other posters, and that this ticker needs to settle above $1.00 to avoid a reverse split. Like many others, I think there are institutional investors at work here trying to make that happen. With that being said, we should see $1.00 hold sooner rather than later.
If we can close above $1.00, the next stop is $1.40. Hold on tight, because it’ll likely happen in the next week or two!
From a technical standpoint, there is considerable support at $.050.
When it comes to charting CANB, I find it easier to use the hourly chart, rather than the daily. This is primarily because the trading/price action seems appears more fluid on an hour-by-hour basis. The daily chart can seem choppy at times because the price action may shutter on large buy/sell orders.
With that being said, the hourly chart closed today with a green hammer on about 200k shares traded. That’s not a huge multiple of shares traded over the preceding days, but it’s enough to give me the impression that it’s not “painted.”
As for the other indicators, the MACD looks over extended and prepared to turn around, and the RSI has already reversed.
I was hoping to get a chance to buy $.050’s later this week, but based on each of the above indications, I think the bottom is in.
Best case, buyers will have 1-2 hours tomorrow morning to get cheapies - if that. Otherwise, be prepared to hit the ask. It looks like I may have to.
I’ll have to close some positions first thing in the morning so I can jump back into CANB, but this ticker has way too much potential to miss out on in the next few days.
On the bright side, I started with CANB last year (last December) with about 40,000 shares. This time, I’m looking to gobble up about 300,000 shares.
For anyone passively reading this board and hesitant about CANB, it’s a no-brainer. Sleek has provided a dummy-proof guide to Canbiola due diligence, and many of the main points have been discussed ad nauseam over the last several weeks. Take the time to read through the posts from this year, and buy some dang shares! You’ll be glad you did!
I’m anxiously awaiting the upcoming 10-Q also, but I’m also taking advantage of these rock-bottom prices. I’d like for us to go a tad bit lower, just so I can grab some $.050’s before next week.
As far as I see it, we’ll be setting new highs in the coming weeks. That means that from current prices, we should see at least 100% gains.
C’mon, who doesn’t love a double?
This is what’s known as a red herring argument, or an attempt to divert one’s attention to something irrelevant.
Anyone who has done an iota of due diligence on Canbiola knows that their business model does not mirror the typical CBD retailers in the industry.
They’re not setting up store fronts or operating huge manufacturing warehouses. Instead, they’re selling out of a huge network of physician offices.
As of last year, they’re focus has been on the medical device aspect of CBD as a treatment option. They didn’t design the device, they don’t manufacture the device, they don’t even service or repair the device.
Instead, they own own the rights to the device, and they have hundreds of physicians renting them out every day. Why do they need a huge workforce for that? Why do they need a huge warehouse for that?
What are your thoughts about this?
Failed catalyst? What are you talking about?
If you’re referencing the 2018 10-K, we jumped 25% in a single day, immediately following it’s release. Since then, just 13 trading sessions later, we’re up another 40%.
As far as I can tell, nobody expected the 2018 10-K to launch CANB to the moon. Likewise, nobody expects the upcoming 10-Q to take us to $1.
From here, what most people do reasonably expect is for CANB to build a base in the $.05 - $.06 range before taking off when the 10-Q is released. That’s exactly what we’re seeing happen.
Based on the recent trading characteristics of Canbiola, it’s not unreasonable to expect $.10 - $.12 by the end of the month.
From today’s close, that’s another 100% gain. From last month’s price, that’s more than a 250% gain.
So far, I’m pretty happy with what Canbiola is doing.